Circular RNA-Based Molecular Computation Enhances Plasma Biomarker Detection in Biliary Tract Cancer
- PMID: 40259434
- DOI: 10.1002/anie.202505289
Circular RNA-Based Molecular Computation Enhances Plasma Biomarker Detection in Biliary Tract Cancer
Abstract
Molecular diagnosis of biliary tract cancer (BTC) remains a significant clinical challenge due to the lack of sensitive and specific diagnostic tools. Although large panels based on multi-biomarkers have demonstrated potential in enhancing diagnostic accuracy, their clinical application is hindered by complexity and high costs. To overcome these limitations, we have developed a DNA-based molecular computation system that integrates the detection of plasma circular RNAs (circRNAs) with molecular computation, enabling intelligent and rapid diagnosis of BTC. By identifying and validating a specific and small set of circRNA biomarkers that are differentially expressed in BTC patients, we designed a DNA computation framework that directly translates biomarker levels into diagnostic outcomes without the need of external analysis and interpretation. In a validation cohort of 70 individuals, our approach achieved a diagnostic accuracy of 83%, demonstrating its potential as a cost-effective and efficient tool for rapid diagnosis of BTC. This work highlights the potential of molecular computation in enhancing integrated and rapid cancer diagnostics, paving the way for clinical implementation.
Keywords: Biliary tract cancer; CircRNA; DNA computation; Liquid biopsy.
© 2025 Wiley‐VCH GmbH.
References
-
- F. Bray, M. Laversanne, H. Sung, J. Ferlay, R. L. Siegel, I. Soerjomataram, A. Jemal, CA Cancer J. Clin. 2024, 74, 229–263.
-
- W. Li, H. Liang, W. Wang, J. Liu, X. Liu, S. Lao, W. Liang, J. He, J Hematol. Oncol. 2024, 17, 99.
-
- J. W. Valle, R. K. Kelley, B. Nervi, D.‐Y. Oh, A. X. Zhu, Lancet 2021, 397, 428–444.
-
- A. J. Scott, S. Reya, R. T. Shroff, J. Clin. Oncol. 2022, 40, 2716–2734.
-
- Y. Zhang, M. Li, X. Gao, Y. Chen, T. Liu, J Hematol. Oncol. 2019, 12, 137.
MeSH terms
Substances
Grants and funding
- YXD24B0403/Zhejiang Provincial Natural Science Foundation of China
- LTGY23H160010/Zhejiang Provincial Natural Science Foundation of China
- 82303291/National Natural Science Foundation of China
- 22104035/National Natural Science Foundation of China
- 2023M733564/China Postdoctoral Science Foundation
- 2023M743555/China Postdoctoral Science Foundation
- ZJSKAXHQLLCKYXM202208/Zhejiang Cancer Society-Qilu Clinical Research Fund
- Special Fund for Clinical Research of Innovative Pharmaceuticals/Zhejiang Cancer Society-Qilu Clinical Research Fund
- WKZX2023CX030001/Zhejiang Cancer Society-Qilu Clinical Research Fund
- 2023020612/Ningbo Top Medical and Health Research Program
- Youth Medical Backbone Talents Training Program of Ningbo
- KF2101/State Key Laboratory of Fine Chemicals, Dalian University of Technology
LinkOut - more resources
Full Text Sources
